does tirzepatide cause memory loss insomnia: what causes sleep problems and how to fix them Tirzepatide: a novel therapeutic approach

Association between severity of kidney disease and primary targets of semaglutide No correlation was found between UACR and HbA1c after either 6 or 12 months of treatment

Metabolic rate typically decreases proportionally as body mass declines during GLP-1 therapy, following the same pattern as weight loss from other methods

Zoubovsky SP, Pogorelov VM, Taniguchi Y, Kim SH, Yoon P, Nwulia E, et al

It indicates the body is having difficulty clearing iron

Both can contribute to allodynia in semaglutide users, and understanding them helps explain why the condition sometimes resolves on its own and sometimes requires intervention